Investor Stock List
Ranked #5,065 of 8,699 institutional investors

Euclidean Capital LLC

New York, NY

$291M
US stock portfolio at live prices · today −$3.8M (−1.30%)
Market closed. Prices as of Nov 20, 8:41 AM ET
Value at quarter end (Q3 2026)
$324M
Change from Q2 2026
−$116.2M (−26.42%)
Positions
10 · 1 new, 1 sold out
Filed
Nov 16, 2026

Holdings

Q3 2026 13F, live prices
VEU 85.0%INDA 6.60%ORIC 2.62%TMS 1.57%PMVP 1.18%
StockSharesValue, live% of portfoliovs Q2 2026
VEU Vanguard FTSE All-World ex-US Index Fund ETF Shares3,243,484$247M85.0%Unchanged
INDA iShares MSCI India ETF369,600$19.2M6.60%Unchanged
ORIC ORIC Pharmaceuticals, Inc.989,410$7.6M2.62%Unchanged
TMS Teamshares Inc.1,099,974$4.6M1.57%Unchanged
PMVP PMV Pharmaceuticals, Inc.2,627,643$3.4M1.18%Unchanged
ALEC Alector, Inc.1,307,858$3.0M1.03%Unchanged
FHTX Foghorn Therapeutics Inc.1,573,761$2.8M0.96%Unchanged
SRZN Surrozen, Inc.87,696$2.7M0.92%Unchanged
TNYA Tenaya Therapeutics, Inc.1,015,705$303K0.10%Unchanged
MRLN Merlin, Inc.47,610$42K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
VTV Vanguard Morningstar Value ETF520,000$113M